Fariba Navid

Fariba Navid is a Professor of Clinical Pediatrics at the Keck School of Medicine of the University of Southern California (USC). Her research focuses on pediatric oncology, with an emphasis on improving outcomes for children with solid tumors such as osteosarcoma, neuroblastoma, rhabdomyosarcoma, and desmoid tumors. She has contributed to clinical trials evaluating novel therapies, including immunotherapies, tyrosine kinase inhibitors, and targeted genomic approaches. Her work integrates molecular diagnostics, pharmacology, and surgical strategies to address challenges in pediatric cancer care.

Education and Affiliations:

• Professor of Clinical Pediatrics at Keck School of Medicine, USC
• Affiliated with Children’s Hospital Los Angeles (CHLA)

Research Interests:

• Molecular mechanisms of pediatric solid tumors
• Clinical trials for novel agents in osteosarcoma and neuroblastoma
• Immunotherapy and antibody-based treatments (e.g., hu1418K322A)
• Genomic profiling and liquid biopsy applications
• Surgical outcomes and metastasectomy strategies

Recent Trends in Publications: Recent work emphasizes translational research, including genomic assays for tumor fusion identification, circulating tumor DNA biomarkers, and phase I/II trials of drug combinations targeting signaling pathways (e.g., IGF-1R/Src). She also explores pharmacotherapy for rare tumors like desmoid-type fibromatosis and malignant rhabdoid tumors.

Advising and Grants: While no specific grants are listed, her extensive publication record suggests involvement in collaborative research funded by institutions like the Children’s Oncology Group. She contributes to task forces prioritizing novel agents for pediatric osteosarcoma trials.

Labs/Teams: Collaborates with multidisciplinary teams at CHLA and USC, focusing on pediatric oncology, molecular diagnostics, and clinical trial design.